{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:20:07Z","timestamp":1761920407967},"reference-count":49,"publisher":"Tohoku University Medical Press","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2018]]},"DOI":"10.1620\/tjem.244.123","type":"journal-article","created":{"date-parts":[[2018,2,14]],"date-time":"2018-02-14T22:12:29Z","timestamp":1518646349000},"page":"123-131","source":"Crossref","is-referenced-by-count":13,"title":["Lower Plasma Levels of IL-35 in Patients with Primary Biliary Cirrhosis"],"prefix":"10.1620","volume":"244","author":[{"given":"Tengda","family":"Li","sequence":"first","affiliation":[{"name":"Center of Clinical Experiments, Changhai Hospital, Second Military Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanlan","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Diagnosis, No. 455 Hospital of People\u2019s Liberation Army of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Liu","sequence":"additional","affiliation":[{"name":"Center of Clinical Experiments, Changhai Hospital, Second Military Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Laboratory Diagnosis, Changhai Hospital, Second Military Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Laboratory Diagnosis, Changhai Hospital, Second Military Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Diagnosis, Changhai Hospital, Second Military Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingli","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Laboratory Diagnosis, Changhai Hospital, Second Military Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Qian","sequence":"additional","affiliation":[{"name":"Department of Laboratory Diagnosis, The 100th Hospital of People\u2019s Liberation Army of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anmei","family":"Deng","sequence":"additional","affiliation":[{"name":"Center of Clinical Experiments, Changhai Hospital, Second Military Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Alunno, A., Manetti, M., Caterbi, S., Ibba-Manneschi, L., Bistoni, O., Bartoloni, E., Valentini, V., Terenzi, R. &amp; Gerli, R. (2015) Altered immunoregulation in rheumatoid arthritis: the role of regulatory T cells and proinflammatory Th17 cells and therapeutic implications. <i>Mediators Inflamm.<\/i>, 2015, 751793.","DOI":"10.1155\/2015\/751793"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Boonstra, K., Beuers, U. &amp; Ponsioen, C.Y. (2012) Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. <i>J. Hepatol.<\/i>, 56, 1181-1188.","DOI":"10.1016\/j.jhep.2011.10.025"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Carey, E.J., Ali, A.H. &amp; Lindor, K.D. (2015) Primary biliary cirrhosis. <i>Lancet<\/i>, 386, 1565-1575.","DOI":"10.1016\/S0140-6736(15)00154-3"},{"key":"4","unstructured":"Collison, L.W., Chaturvedi, V., Henderson, A.L., Giacomin, P.R., Guy, C., Bankoti, J., Finkelstein, D., Forbes, K., Workman, C.J., Brown, S.A., Rehg, J.E., Jones, M.L., Ni, H.T., Artis, D., Turk, M.J. &amp; Vignali, D.A. (2010) IL-35-mediated induction of a potent regulatory T cell population. <i>Nat. Immunol.<\/i>, 11, 1093-1101."},{"key":"5","unstructured":"Collison, L.W., Delgoffe, G.M., Guy, C.S., Vignali, K.M., Chaturvedi, V., Fairweather, D., Satoskar, A.R., Garcia, K.C., Hunter, C.A., Drake, C.G., Murray, P.J. &amp; Vignali, D.A. (2012) The composition and signaling of the IL-35 receptor are unconventional. <i>Nat. Immunol.<\/i>, 13, 290-299."},{"key":"6","doi-asserted-by":"crossref","unstructured":"Collison, L.W., Workman, C.J., Kuo, T.T., Boyd, K., Wang, Y., Vignali, K.M., Cross, R., Sehy, D., Blumberg, R.S. &amp; Vignali, D.A. (2007) The inhibitory cytokine IL-35 contributes to regulatory T-cell function. <i>Nature<\/i>, 450, 566-569.","DOI":"10.1038\/nature06306"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Corpechot, C., Abenavoli, L., Rabahi, N., Chretien, Y., Andreani, T., Johanet, C., Chazouilleres, O. &amp; Poupon, R. (2008) Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis. <i>Hepatology<\/i>, 48, 871-877.","DOI":"10.1002\/hep.22428"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Dos Passos, G.R., Sato, D.K., Becker, J. &amp; Fujihara, K. (2016) Th17 Cells Pathways in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders: Pathophysiological and Therapeutic Implications. <i>Mediators Inflamm.<\/i>, 2016, 5314541.","DOI":"10.1155\/2016\/5314541"},{"key":"9","unstructured":"Fenoglio, D., Bernuzzi, F., Battaglia, F., Parodi, A., Kalli, F., Negrini, S., De Palma, R., Invernizzi, P. &amp; Filaci, G. (2012) Th17 and regulatory T lymphocytes in primary biliary cirrhosis and systemic sclerosis as models of autoimmune fibrotic diseases. <i>Autoimmun. Rev.<\/i>, 12, 300-304."},{"key":"10","doi-asserted-by":"crossref","unstructured":"Filaci, G., Fenoglio, D. &amp; Indiveri, F. (2011) CD8(+) T regulatory\/suppressor cells and their relationships with autoreactivity and autoimmunity. <i>Autoimmunity<\/i>, 44, 51-57.","DOI":"10.3109\/08916931003782171"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Gee, K., Guzzo, C., Che Mat, N.F., Ma, W. &amp; Kumar, A. (2009) The IL-12 family of cytokines in infection, inflammation and autoimmune disorders. <i>Inflamm. Allergy Drug Targets<\/i>, 8, 40-52.","DOI":"10.2174\/187152809787582507"},{"key":"12","unstructured":"Griffiths, L., Dyson, J.K. &amp; Jones, D.E. (2014) The new epidemiology of primary biliary cirrhosis. <i>Semin. Liver Dis.<\/i>, 34, 318-328."},{"key":"13","doi-asserted-by":"crossref","unstructured":"Guan, S.Y., Leng, R.X., Khan, M.I., Qureshi, H., Li, X.P., Ye, D.Q. &amp; Pan, H.F. (2017) Interleukin-35: a Potential Therapeutic Agent for Autoimmune Diseases. <i>Inflammation<\/i>, 40, 303-310.","DOI":"10.1007\/s10753-016-0453-9"},{"key":"14","unstructured":"Hirschfield, G.M. &amp; Gershwin, M.E. (2013) The immunobiology and pathophysiology of primary biliary cirrhosis. <i>Annu. Rev. Pathol.<\/i>, 8, 303-330."},{"key":"15","unstructured":"Imam, M.H. &amp; Lindor, K.D. (2014) The natural history of primary biliary cirrhosis. <i>Semin. Liver Dis.<\/i>, 34, 329-333."},{"key":"16","unstructured":"Kleinewietfeld, M. &amp; Hafler, D.A. (2013) The plasticity of human Treg and Th17 cells and its role in autoimmunity. <i>Semin. Immunol.<\/i>, 25, 305-312."},{"key":"17","doi-asserted-by":"crossref","unstructured":"Kochetkova, I., Golden, S., Holderness, K., Callis, G. &amp; Pascual, D.W. (2010) IL-35 stimulation of CD39+ regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10. <i>J. Immunol.<\/i>, 184, 7144-7153.","DOI":"10.4049\/jimmunol.0902739"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Kumar, N.P., Moideen, K., George, P.J., Dolla, C., Kumaran, P. &amp; Babu, S. (2016) Coincident diabetes mellitus modulates Th1-, Th2-, and Th17-cell responses in latent tuberculosis in an IL-10- and TGF-<i>\u03b2<\/i>-dependent manner. <i>Eur. J. Immunol.<\/i>, 46, 390-399.","DOI":"10.1002\/eji.201545973"},{"key":"19","unstructured":"Lacerda, M.A., Ludwig, J., Dickson, E.R., Jorgensen, R.A. &amp; Lindor, K.D. (1995) Antimitochondrial antibody-negative primary biliary cirrhosis. <i>Am. J. Gastroenterol.<\/i>, 90, 247-249."},{"key":"20","unstructured":"Lan, R.Y., Salunga, T.L., Tsuneyama, K., Lian, Z.X., Yang, G.X., Hsu, W., Moritoki, Y., Ansari, A.A., Kemper, C., Price, J., Atkinson, J.P., Coppel, R.L. &amp; Gershwin, M.E. (2009) Hepatic IL-17 responses in human and murine primary biliary cirrhosis. <i>J. Autoimmun.<\/i>, 32, 43-51."},{"key":"21","doi-asserted-by":"crossref","unstructured":"Li, X., Mai, J., Virtue, A., Yin, Y., Gong, R., Sha, X., Gutchigian, S., Frisch, A., Hodge, I., Jiang, X., Wang, H. &amp; Yang, X.F. (2012) IL-35 is a novel responsive anti-inflammatory cytokine: a new system of categorizing anti-inflammatory cytokines. <i>PLoS ONE<\/i>, 7, e33628.","DOI":"10.1371\/journal.pone.0033628"},{"key":"22","unstructured":"Liu, B., Zhang, X., Zhang, F.C., Zong, J.B., Zhang, W. &amp; Zhao, Y. (2013) Aberrant TGF-<i>\u03b2<\/i>1 signaling contributes to the development of primary biliary cirrhosis in murine model. <i>World J. Gastroenterol.<\/i>, 19, 5828-5836."},{"key":"23","unstructured":"Lleo, A., Maroni, L., Glaser, S., Alpini, G. &amp; Marzioni, M. (2014) Role of cholangiocytes in primary biliary cirrhosis. <i>Semin. Liver Dis.<\/i>, 34, 273-284."},{"key":"24","unstructured":"Mannino, M.H., Zhu, Z., Xiao, H., Bai, Q., Wakefield, M.R. &amp; Fang, Y. (2015) The paradoxical role of IL-10 in immunity and cancer. <i>Cancer Lett.<\/i>, 367, 103-107."},{"key":"25","doi-asserted-by":"crossref","unstructured":"Mattner, F., Magram, J., Ferrante, J., Launois, P., Di Padova, K., Behin, R., Gately, M.K., Louis, J.A. &amp; Alber, G. (1996) Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. <i>Eur. J. Immunol.<\/i>, 26, 1553-1559.","DOI":"10.1002\/eji.1830260722"},{"key":"26","unstructured":"Miao, J., Zhang, K., Lv, M., Li, Q., Zheng, Z., Han, Q., Guo, N., Fan, C. &amp; Zhu, P. (2014) Circulating Th17 and Th1 cells expressing CD161 are associated with disease activity in rheumatoid arthritis. <i>Scand. J. Rheumatol.<\/i>, 43, 194-201."},{"key":"27","unstructured":"Moore, K.W., de Waal Malefyt, R., Coffman, R.L. &amp; O\u2019Garra, A. (2001) Interleukin-10 and the interleukin-10 receptor. <i>Annu. Rev. Immunol.<\/i>, 19, 683-765."},{"key":"28","unstructured":"Niedbala, W., Wei, X.Q., Cai, B., Hueber, A.J., Leung, B.P., McInnes, I.B. &amp; Liew, F.Y. (2007) IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. <i>Eur. J. Immunol.<\/i>, 37, 3021-3029."},{"key":"29","doi-asserted-by":"crossref","unstructured":"Nieuwenhuis, E.E., Neurath, M.F., Corazza, N., Iijima, H., Trgovcich, J., Wirtz, S., Glickman, J., Bailey, D., Yoshida, M., Galle, P.R., Kronenberg, M., Birkenbach, M. &amp; Blumberg, R.S. (2002) Disruption of T helper 2-immune responses in Epstein-Barr virus-induced gene 3-deficient mice. <i>Proc. Natl. Acad. Sci. USA<\/i>, 99, 16951-16956.","DOI":"10.1073\/pnas.252648899"},{"key":"30","unstructured":"Ning, X., Jian, Z. &amp; Wang, W. (2015) Low serum levels of interleukin 35 in patients with rheumatoid arthritis. <i>Tohoku J. Exp. Med.<\/i>, 237, 77-82."},{"key":"31","unstructured":"Pylayeva-Gupta, Y. (2016) Molecular pathways: interleukin-35 in autoimmunity and cancer. <i>Clin. Cancer Res.<\/i>, 22, 4973-4978."},{"key":"32","doi-asserted-by":"crossref","unstructured":"Qian, C., Jiang, T., Zhang, W., Ren, C., Wang, Q., Qin, Q., Chen, J., Deng, A. &amp; Zhong, R. (2013) Increased IL-23 and IL-17 expression by peripheral blood cells of patients with primary biliary cirrhosis. <i>Cytokine<\/i>, 64, 172-180.","DOI":"10.1016\/j.cyto.2013.07.005"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Raphael, I., Nalawade, S., Eagar, T.N. &amp; Forsthuber, T.G. (2015) T cell subsets and their signature cytokines in autoimmune and inflammatory diseases. <i>Cytokine<\/i>, 74, 5-17.","DOI":"10.1016\/j.cyto.2014.09.011"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Rong, G., Zhou, Y., Xiong, Y., Zhou, L., Geng, H., Jiang, T., Zhu, Y., Lu, H., Zhang, S., Wang, P., Zhang, B. &amp; Zhong, R. (2009) Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: the serum cytokine profile and peripheral cell population. <i>Clin. Exp. Immunol.<\/i>, 156, 217-225.","DOI":"10.1111\/j.1365-2249.2009.03898.x"},{"key":"35","unstructured":"Rosenbloom, J., Castro, S.V. &amp; Jimenez, S.A. (2010) Narrative review: fibrotic diseases: cellular and molecular mechanisms and novel therapies. <i>Ann. Intern. Med.<\/i>, 152, 159-166."},{"key":"36","unstructured":"Saeki, R., Ogino, H., Kaneko, S., Unoura, M. &amp; Kobayashi, K. (1995) Effects of chenodeoxycholic and ursodeoxycholic acids on interferon-gamma production by peripheral blood mononuclear cells from patients with primary biliary cirrhosis. <i>J. Gastroenterol.<\/i>, 30, 739-744."},{"key":"37","unstructured":"Sakaguchi, S., Powrie, F. &amp; Ransohoff, R.M. (2012) Re-establishing immunological self-tolerance in autoimmune disease. <i>Nat. Med.<\/i>, 18, 54-58."},{"key":"38","unstructured":"Shindo, M., Mullin, G.E., Braun-Elwert, L., Bergasa, N.V., Jones, E.A. &amp; James, S.P. (1996) Cytokine mRNA expression in the liver of patients with primary biliary cirrhosis (PBC) and chronic hepatitis B (CHB). <i>Clin. Exp. Immunol.<\/i>, 105, 254-259."},{"key":"39","unstructured":"Ueno, A., Ghosh, A., Hung, D., Li, J. &amp; Jijon, H. (2015) Th17 plasticity and its changes associated with inflammatory bowel disease. <i>World J. Gastroenterol.<\/i>, 21, 12283-12295."},{"key":"40","unstructured":"Vignali, D.A. &amp; Kuchroo, V.K. (2012) IL-12 family cytokines: immunological playmakers. <i>Nat. Immunol.<\/i>, 13, 722-728."},{"key":"41","unstructured":"Waluga, M., Kukla, M., Zorniak, M., Kochel-Jankowska, A., Kajor, M., Krzeminski, T. &amp; Kotulski, R. (2015) Visfatin and TGF-Beta1 in primary biliary cirrhosis and two other common liver diseases. <i>Folia Med. Cracov.<\/i>, 55, 59-70."},{"key":"42","unstructured":"Wang, D., Zhang, H., Liang, J., Gu, Z., Zhou, Q., Fan, X., Hou, Y. &amp; Sun, L. (2010) CD4+ CD25+ but not CD4+ Foxp3+ T cells as a regulatory subset in primary biliary cirrhosis. <i>Cell. Mol. Immunol.<\/i>, 7, 485-490."},{"key":"43","doi-asserted-by":"crossref","unstructured":"Wang, L., Sun, Y., Zhang, Z., Jia, Y., Zou, Z., Ding, J., Li, Y., Xu, X., Jin, L., Yang, T., Li, Z., Sun, Y., Zhang, J.Y., Lv, S., Chen, L., et al. (2015a) CXCR5+ CD4+ T follicular helper cells participate in the pathogenesis of primary biliary cirrhosis. <i>Hepatology<\/i>, 61, 627-638.","DOI":"10.1002\/hep.27306"},{"key":"44","doi-asserted-by":"crossref","unstructured":"Wang, Y.H., Yang, W., Yang, J.B., Jia, Y.J., Tang, W., Gershwin, M.E., Ridgway, W.M. &amp; Lian, Z.X. (2015b) Systems biologic analysis of T regulatory cells genetic pathways in murine primary biliary cirrhosis. <i>J. Autoimmun.<\/i>, 59, 26-37.","DOI":"10.1016\/j.jaut.2015.01.011"},{"key":"45","unstructured":"Webb, G.J., Siminovitch, K.A. &amp; Hirschfield, G.M. (2015) The immunogenetics of primary biliary cirrhosis: a comprehensive review. <i>J. Autoimmun.<\/i>, 64, 42-52."},{"key":"46","doi-asserted-by":"crossref","unstructured":"Wirtz, S., Billmeier, U., McHedlidze, T., Blumberg, R.S. &amp; Neurath, M.F. (2011) Interleukin-35 mediates mucosal immune responses that protect against T-cell-dependent colitis. <i>Gastroenterology<\/i>, 141, 1875-1886.","DOI":"10.1053\/j.gastro.2011.07.040"},{"key":"47","unstructured":"Yamaguchi, T., Wing, J.B. &amp; Sakaguchi, S. (2011) Two modes of immune suppression by Foxp3(+) regulatory T cells under inflammatory or non-inflammatory conditions. <i>Semin. Immunol.<\/i>, 23, 424-430."},{"key":"48","doi-asserted-by":"crossref","unstructured":"Yang, C.Y., Ma, X., Tsuneyama, K., Huang, S., Takahashi, T., Chalasani, N.P., Bowlus, C.L., Yang, G.X., Leung, P.S., Ansari, A.A., Wu, L., Coppel, R.L. &amp; Gershwin, M.E. (2014a) IL-12\/Th1 and IL-23\/Th17 biliary microenvironment in primary biliary cirrhosis: implications for therapy. <i>Hepatology<\/i>, 59, 1944-1953.","DOI":"10.1002\/hep.26979"},{"key":"49","doi-asserted-by":"crossref","unstructured":"Yang, Y., Xuan, M., Zhang, X., Zhang, D., Fu, R., Zhou, F., Ma, L., Li, H., Xue, F., Zhang, L. &amp; Yang, R. (2014b) Decreased IL-35 levels in patients with immune thrombocytopenia. <i>Hum. Immunol.<\/i>, 75, 909-913.","DOI":"10.1016\/j.humimm.2014.06.019"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/244\/2\/244_123\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T06:28:46Z","timestamp":1719815326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/244\/2\/244_123\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.244.123","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}